Vaccaria segetalis: A Review of Ethnomedicinal, Phytochemical, Pharmacological, and Toxicological Findings.

Vaccaria segetalis is a dry mature seed of Vaccaria hispanica (Mill.) Rauschert, which belongs to the genus V. segetalis (Neck.) Garcke. There are multiple medicinal parts of V. segetalis, according to the records, including roots, stems, leaves, flowers, and seeds, which should be used together. Currently, V. segetalis is most frequently used in the treatment of menstruation, dysmenorrhea, breast milk stoppages, and chylorrhea. Numerous studies present historical evidence of the use of V. segetalis to treat several diseases and describe its beneficial effects including prolactin- (PRL-) like, estrogen-like, antitumor, antiangiogenesis, and antioxidant activity. We summarized the period from January 1980 to December 2019 regarding V. segetalis. This review paper indicates that V. segetalis has promising clinical applications. The main active ingredients of the plant have been elucidated in recent years. We summarized the previously and newly discovered pharmacological effects of V. segetalis in addition to its active ingredients, ethnopharmacological uses, and toxicological properties, and provided a focus for future research.

Introduction

Vaccaria segetalis (Neck.) Garcke is an annual herb and is widely distributed worldwide throughout the cold temperature zone. The seeds of V. segetalis, which are known as Wang Bu Liu Xing, have been used in traditional Chinese medicine (TCM) to treat amenorrhea, dysmenorrhea, lactation failures, and carbuncles (Sang et al., 2003). V. segetalis has been used in China for 2000 years as documented in the oldest materia medica Shen Nong Ben Cao Jing. In recent years, being its clinical application more extensive, and many new clinical applications, such as the treatment of shingles (Min-ying, 2005), gallstones (Zhi-hong and Cai-ying, 1989), hypertension (Liu, 2018), and rhinitis (Liang and Xiu-jun, 2013), have been identified. V. segetalis is composed of several chemical components. Saponins (Ma et al., 2008), flavonoids (Wang et al., 2011), polysaccharides (Qing et al., 2014), and cyclic peptides (Sang et al., 2002) are believed to be the principal active constituents of V. segetalis. The seeds also contain components such as coumarins, lipids, fatty acids, and metallic elements (Jin-Ling et al., 2014). Recently, an increasing number of studies have suggested that V. segetalis extract has various bioactivities, such as prolactin- (PRL-) like, estrogen-like, antitumor, antiangiogenesis, and antioxidant activity, and it is also shown to dilate blood vessels and relieve osteoporosis (Li-Fan and Liang, 2007). This article also summarizes toxicological research regarding V. segetalis.

Complementary/alternative medicine has developed rapidly in recent years, and its use has gradually expanded globally. The use of Chinese herbal medicine as a part of complementary/alternative medicine has been the focus of many scholars. Although a few literature studies have described V. segetalis to date, no article has systematically summarized and evaluated the research results. We conducted this review to summarize the existing literature studies and to focus on analyses of the chemical constituents and pharmacological activities of V. segetalis. Our goal is to permit other researchers to more easily review existing research and provide new directions for future research.

Ethnopharmacological Uses

Preparation of V. segetalis

Dry mature seeds from V. segetalis were prepared by using a multistep process. V. segetalis has different traits in different preparation stages (Tian-Yi, 2011). A specific preparation method is described below. In the first stage, after the fruits mature in summer, the plants are cut and dried. Then, the seeds are beat and dried. During this time, the seed is a black sphere with a diameter of approximately 2 mm. In the second stage, the seeds are fried until most seeds burst into white flowers. In the final stage, the seeds that burst into white flowers are ground into powder.

Methods of Administration

There are three administration methods for different preparation stages of V. segetalis because of its different traits. In the first type, seeds can be applied directly by pressing acupoints. In the second type, the seeds are fried until the white flowers burst, and the seeds are decocted in water. In the third type, the ground powder is applied directly to the affected area.

Indication

The seeds of V. segetalis are often used as black spheres in acupressure methods. Based on the TCM theory, acupoints are the specifically chosen sites for physical stimulation (Rong et al., 2011). A few studies have revealed that stimulating different acupoints on the body surface could provide various therapeutic benefits (Li et al., 2015). Previous research illustrated that pressing acupoints with seeds can improve hypertension. In one study, Liu (2018) selected the auricular points that were related to blood pressure, pressed one seed at each acupoint, and kneaded each acupoint for 3–5 min. This treatment was performed thrice a day, and the contralateral acupoints were alternatively pressed every 3 days. After 2 weeks of treatment, the hypertension symptoms of a patient had resolved (Liu, 2018). Gallstones can also be treated in this manner. In another study, the researchers used the seeds of V. segetalis to press the gallbladder, liver, duodenum, and sympathetic points on both sides of the ears of patients dozens of times and found that the gallbladder contracted significantly. Consequently, small stones and silt-like stones in the gallbladder were discharged into the intestinal lumen with bile, and then excreted from the body (Zhi-hong and Cai-ying, 1989). In addition, this method was used to treat rhinitis. A research team also used the seeds to press the ear points that were related to the nose 3–5 times a day, for 1–3 min each time. Ear points were changed every 3 days, switching between the two ears, and the course of treatment was 10 days (Liang and Xiu-jun, 2013). V. segetalis as a white flower after frying is often used in water decoctions. V. segetalis has also been used in combination with other Chinese herbal medicine to treat gonorrhea and promote the milk production. According to The Precious Mirror of Hygiene (AD 1343), ancient Chinese herbalists used V. segetalis to boost the milk production and milk lactation. The traditional Chinese herbal medicine prescription consists of equal amount of the spike of Dianthus superbus L., Ophiopogon japonicas (L.f.) Ker-Gawl (inner column removal), V. segetalis, fossil fragments (ancient mammals such as elephants, rhinos, three-toed horses, cattle, and deer), and the scale of Manis pentadactyla Linnaeus to the total of 50 g. The components are mixed and ground into a powder. In total, 5 g of the mixture are consumed with hot wine thrice a day. Then, 5 g of the mixture are added to a soup consisting of pork knuckle and Akebia quinata (Houtt.) Decne. and consumed thrice a day. Finally, the remaining mixture is rubbed on the left and right breasts 30 times with a wooden comb after consuming the aforementioned soup thrice a day (Tian-Yi, 2011). In recent years, a new application method has been to grind the white flower into a powder for an external application on the affected area. This was proven to be effective for treating shingles (Min-ying, 2005).

In summary, the applications of V. segetalis have been gradually expanded and improved with the accumulated research data. V. segetalis can be used externally or internally. It has been used for a long time based on the physical properties of the seeds to stimulate acupuncture points to treat diseases and their mixing in water decoctions with the other Chinese herbs. The newest application method is a direct application of the powder to the wound surface to treat shingles. We speculate that these activities are related to the active ingredients in seeds. We believe that the in-depth studies of V. segetalis will increase its clinical applications.

Primary Active Ingredients in V. SEGETALIS

Vaccaria segetalis is mainly composed of saponins, cyclic peptides, flavonoids, and polysaccharides, and the other components include volatile oils, coumarins, lipids, and fatty acids. Several studies have investigated these active substance constituents.

Saponins

Several types of saponins are present in the seeds of V. segetalis. These saponins primarily include quillaic acid compounds, which account for ~65% of the total (Table 1). The other saponins include gypsogenin bisdesmosides (~15%), gypsogenic acid monodesmosides (~10%), and vaccaric acid bisdesmosides (~10%). The structures of the known saponins are summarized in Table 1. Triterpenoid saponins are the main components of V. segetalis. They are oleanol-type pentacyclic triterpenoids, which are also known as β-aromatic alkanes. These compounds are widely distributed in the plant kingdom. Triterpenoid saponins mostly have antioxidant (Guan et al., 2013), antitumor (Bozak et al., 1990; Haralampidis et al., 2002; Choi et al., 2005), and anti-inflammatory effects (Bernard et al., 2001; Banno et al., 2005; Guan et al., 2013). They also protect the cardiovascular system through their antihypertensive, anti-atherosclerotic, and vasodilatory effects (Rosalía et al., 2004). The main pharmacological activities of Panax ginseng C. A. Meyer, Glycyrrhiza uralensis Fisch., and Bupleurum L, which are widely used in daily life, are derived from their saponin components.

Table 1

Saponins present in the seeds of Vaccaria segetalis.

Saponins	Formulae	Structure	Pharmacological activities	References
Segetosides
Segetoside B	C69H106O33		Inhibition of luteal cell	Sang et al., 2002
Segetoside C	C56H88O32		Unknown	Sang et al., 1999
Segetoside(D–E)	Common structure
Segetoside D	C69H106O34		Anti-cancer	Güçlü-Ustündag and Mazza, 2007
Segetoside E	C72H112O34		Unknown	Sang et al., 1999
Segetoside(F–I)	Common structure
Segetoside F	C67H104O32		Inhibition of luteal cell	Sang et al., 2000d
Segetoside G	C70H110O32		Unknown	Sang et al., 2000a
Segetoside H	C68H104O33		Unknown	Sang et al., 2000a
Segetoside I	C68H104O34		Anti-tumor activity; Activation of apoptotic	Sang et al., 2000b
Segetoside K	C54H86O26		Unknown	Sang et al., 2000a
Segetoside L	C60H98O28		Unknown	Minliangzou and Ainalao, 1999
Vaccarosides
Vaccaroside (A–C)	Common structure
Vaccaroside A	C54H86O25		Unknown	Sang et al., 1999
Vaccaroside B	C60H94O29		Unknown	Ma et al., 2008
Vaccaroside C	C54H86O25		Unknown	Koike et al., 1998
Vaccaroside D	C54H86O25		Unknown	Koike et al., 1998
Vaccaroside (E–H)	Common structure
Vaccaroside E	C66H102O33		Unknown	Jia et al., 1998
Vaccaroside F	C65H102O33		Unknown	Jia et al., 1998
Vaccaroside G	C66H102O32		Unknown	Jia et al., 1998
Vaccaroside H	C65H102O32		Unknown	Jia et al., 1998
Vaccaroside I	C71H112O37		Unknown	Ma et al., 2008

Cyclic Peptides

Cyclic peptides have been found in several medicinal species such as Pseudostellaria heterophylla Miq., Lycium chinense Mill., and Psammosilene tunicoides, and exhibit a wide range of structure-dependent bioactivities (Tan and Zhou, 2006). Cyclic peptides are important components of V. segetalis (Dahiya and Dahiya, 2021). With the development and integration of modern medicine and traditional complementary medicine, the roles of cyclic peptides have been further confirmed. To date, eight cyclic peptides have been isolated from the seeds of V. segetalis (Table 2). Cyclic peptide molecules have antitumor activity (Feng et al., 2012), and they regulate uterine contraction, which implies estrogen-like activity for segetalins A, B, G, and H (Itokawa et al., 1995; Yun et al., 1997). In addition, a few studies illustrated that segetalins A, D, F, and G have vasodilatory activity against norepinephrine-induced aortic contraction in rats (Morita et al., 1997a). The pharmacological effects of cyclic peptides provide new options for the treatment of diseases.

Table 2

Cyclic peptides present in the seeds of V. segetalis.

Cyclic peptide	Formulae	Structure	Pharmacological activities	References
Segetalins A	C31H43N7O6		Vasorelaxant activity; Estrogen-like activity	Morita et al., 2006
Segetalins B	C24H32N6O5		Estrogen-like activity	Morita et al., 1997b
Segetalins C	C40H51N9O7		Antimicrobial activity	Dahiya and Kaur, 2008
Segetalins D	C37H49N7O8		Estrogen-like activity	Morita et al., 1997a
Segetalins E	C43H56N8O8		Unknown	Sang et al., 2000d
Segetalins F	C44H62N10O14		Vasorelaxant activity	Morita et al., 2006
Segetalins G	C25H38N6O6		Estrogen-like activity; Diastolic activity	Yun et al., 1997
Segetalins H	C29H38N8O8		Estrogen-like activity; Vasodilatory activity	Yun et al., 1997

Flavonoids

Flavonoids comprise a broad class of ketone containing compounds that exist widely in nature. Flavonoids are widely distributed in plants in the form of glycosides, which are called flavonoid glycosides. In particular, Sophora japonica, Scutellaria baicalensis, Pueraria lobata, and Ginkgo biloba are rich in flavonoids. The structure of vaccarin, a flavone isolated from the seeds of V. segetalis, is presented in Figure 1 (Sang et al., 2000c). Flavonoids have many effects, such as protective effects on endothelial cells (Kozlowska and Szostak-Wegierek, 2014), hypoglycemic effects (Chen et al., 2017), antiviral effects (Zakaryan et al., 2017), and the ability to enhance lactation capacity (Tong et al., 2013).

Figure 1

Structure of vaccarin.

Polysaccharides

Polysaccharides are formed by the polymerization of more than 10 monosaccharide molecules via glycosidic bonds. They have high molecular weights, and they usually consist of several hundreds to thousands of monosaccharide molecules. Polysaccharides and their derivatives, such as lentinan, Astragalus polysaccharide, Polyporus polysaccharide, Lycium barbarum polysaccharide, and Ganoderma lucidum polysaccharide, are bioactive substances in TCM. They have antitumor (Mao et al., 2016; Tang et al., 2016), antioxidant (Hui et al., 2019), and anti-inflammatory effects (Wang et al., 2019), and promote cell proliferation (Zheng et al., 2014). Polysaccharides have been isolated from the seeds of V. segetalis in recent years (Zhou et al., 2015). Various active ingredients in V. segetalis provide a theoretical and realistic basis for the study of its pharmacological effects.

Other Components of V. segetalis

V. segetalis also contains coumarins, lipids, fatty acids, and other ingredients, along with adenosine and adenine. The main components of V. segetalis volatile oils are oleic acid amide, n-octadecane, myristylamide, and n-pentadecane (Yun et al., 1998). In addition to the currently known major active ingredients, several unknown ingredients of the plant require further investigation to be identified.

Pharmacological Activity of V. SEGETALIS

Recently, V. segetalis has mainly been used in folk medicine based on its anti-inflammatory, antioxidant, anti-angiogenic, and antitumor effects, in addition to its ability to promote vasodilation, muscle contraction, and lactation. The active ingredients responsible for these effects are polysaccharides, saponins, flavonoids, and cyclic peptides (Peng et al., 2014). We will now specifically introduce its pharmacological activities.

Anti-inflammatory Activity

According to Shen Nong Ben Cao Jing, V. segetalis has been used to treat urinary symptoms such as blood strangury for 2000 years. Gonorrhea in Chinese medicine refers to diseases such as urinary tract infection, prostatitis, and seminal vesicle inflammation. The traditional Chinese herbal medicine prescription is as follows: 30 g of the seeds of V. segetalis and 6 g each of the roots of Angelica sinensis Diels, Chinese teasel, Paeonia lactiflora Pall., and Salvia miltiorrhiza are orally administered as two doses via decoction (Zhu-mo, 2005). Based on an extensive application of V. segetalis in the treatment of inflammatory diseases, we searched and collated the articles published in the past 30 years to explore the intrinsic mechanism of V. segetalis in the treatment of inflammatory diseases.

Hypaphorine from the different sources exhibits anti-inflammatory properties (Silva et al., 2012). V. segetalis extract, along with its hypaphorine, displayed anti-inflammatory activity both in vitro and in vivo (Aswad et al., 2018). In this study, mice were intraperitoneally injected with 200 mg/kg of the 6.019% of Vaccaria hydroalcoholic extract, and the results suggested that it could significantly inhibit xylene-induced ear edema and reduce peritoneal capillary permeability and leukocyte infiltration induced by an intraperitoneal injection of acetic acid (Wang et al., 2015). Similar results were obtained in cells. For example, Sun et al. (2017) found that the Vaccaria hypaphorine concentration dependently downregulated the expression of inflammatory cytokine and inflammatory enzyme, and then counteracted the increased phosphorylation of nucleus transfer-related proteins that were induced by inflammation, thereby inhibiting a nuclear factor- (NF-) κB signaling pathway to exert its anti-inflammatory effect in lipopolysaccharide- (LPS-) stimulated Raw 264.7 cells. Osteoclasts are the only cells in the human body that undergo the bone resorption. Inhibiting the differentiation and formation of osteoclasts can effectively inhibit bone loss and osteolysis (Wei et al., 2018). A previous study suggested that Vaccaria hypaphorine inhibits the formation, differentiation, and resorption of osteoclast to attenuate inflammatory bone loss in LPS-treated mice by inhibiting an extracellular signal-regulated kinase (ERK), p38, a c-Jun N-terminal kinase (JNK), and an NF-κB p65 phosphorylation (Chen et al., 2018). However, Liu et al. (2019) demonstrated that Vaccaria inhibits formation and function of osteoclast in vivo and in vitro, as well as Ti particle-induced osteolysis. Chronic pelvic inflammatory disease (CPID) refers to chronic inflammation of the female internal organs, surrounding connective tissue, and pelvic peritoneum (Chen, 2012; Bu et al., 2015). Man Pen Fang (MPF), a Chinese herbal compound consisting of the whole plants of Thlaspi arvense L. (Cruciferae), Gleditsia sinensis Lam. (Fabaceae), Smilax china L. (Liliaceae), Euonymus alatus (Thunb.) Sieb. (Celastraceae), and the seeds of V. segetalis (Neck; Caryophyllaceae), was proven to be effective for treating CPID in the previous studies (Kim et al., 2015; Li et al., 2016). In this formulation, V. segetalis (Neck) plays an important role because it has analgesic and anti-inflammatory properties, and activates blood circulation by dissipating blood stasis. In previous studies, Zhang et al. (2017) constructed a CPID mouse model (Tuffrey et al., 1992; Chen et al., 2008) and treated the animals with MPF. They revealed that MPF has a significant dose-dependent anti-inflammatory effect during the CPID treatment, and it also plays a positive role by decreasing the serum levels of inflammatory cytokines such as interleukin- (IL-) 6, IL-10, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β (Zhang et al., 2017). Zhang et al. (2017) conducted mechanistic research on TCMs and provided a theoretical support for the use of MPF to treat CPID. Trichinosis is an infectious disease caused by parasites, and it poses a serious hazard to the pork industry and human health (Rostami et al., 2017). In the host, Trichinella activates inflammatory cells to overexpress cyclooxygenase-2 (COX-2; Othman et al., 2016) and other inflammatory factors. Xu et al. (2019) demonstrated that Vaccaria n-butanol extract (VNE) from the seeds of V. segetalis can significantly relieve the symptoms of Trichinella spiralis infection. However, VNE from the seeds of V. segetalis did not significantly and directly affect the viability of T. spiralis muscle larvae. The study suggested that the survival rate of T. spiralis muscle larvae did not differ between the control and VNE treatment. Moreover, VNE exerted anti-inflammatory effects by repressing the IL-1β, IL-6, TNF-α, and COX-2 expression in mice. Therefore, it was speculated that VNE is likely to exert its anti-inflammatory effect by reducing the inflammatory response in infected mice and exhibiting similar insecticidal effects to T. spiralis (Xu et al., 2019). Albendazole is commonly used to treat human trichinellosis. However, because of its clinical side effects, VNE may be an adjuvant to the existing drug. A recent study provided insights into the mechanism of the anti-inflammatory effects of V. segetalis. Mao found that crude polysaccharides from the seeds of V. segetalis (SVCP) can effectively prevent the urinary tract infections that are induced by uropathogenic Escherichia coli (UPEC) in 2020. SVCP-induced upregulation of IL-6 and IL-8 helps to eliminate bacteria in the urine, and does not cause tissue damage and acute pyelonephritis via the upregulation of pro-inflammatory cytokines. In addition, the authors found that the application of SVCP could upregulate the PIGR expression in rat kidneys, which was significantly suppressed by UPEC (Mao et al., 2020). This suggests that SVCP can prevent the infection caused by UPEC by stimulating an innate immunity of the kidneys. In addition, (Mao et al., 2021) explored the potential mechanism of SVCP in the treatment of kidney infections in a recent research study. The administration of SVCP upregulated the low expression of Cathelicidin family (LL-37 and CRAMP) in the UPEC-induced kidney infection model, and upregulated the expression of Toll-like receptors (TLRs). TLR agonists can stimulate the expression of cathelicidin (Liu et al., 2006; Vandamme et al., 2012). In summary, SVCP may increase the expression of cathelicidin by activating TLRS to protect the kidney from infection. This enriches the mechanism of action of SVCP.

Currently, antibiotics are the most widely used drugs to treat inflammation-related diseases. However, the long-term use of antibiotics in large quantities will lead to drug resistance and cause serious side effects in some patients, leading to treatment failures. The anti-inflammatory effect of V. segetalis provides new avenues for the treatment of inflammatory diseases.

Anticancer Activity

In 1971, Folkman (1971) first proposed the theory of tumor angiogenesis. Through an in-depth study of malignancies, the researchers found that angiogenesis is an important process in tumorigenesis and tumor development. Angiogenesis can be activated at different stages of tumor development. Currently, anti-angiogenic drugs represent a leading field in the development of new antitumor drugs (Viallard and Larrivee, 2017). The inhibition of angiogenesis has become a necessary strategy for antitumor therapy (D'Amato and Adamis, 1995; Folkman, 1995; Tímár et al., 2001). Continuous proliferation and migration of vascular endothelial cells are the primary steps in angiogenesis. During the neovascularization, endothelial cells first establish a cell-to-cell contact and then proliferate and migrate to a perivascular matrix where cellular connections are re-established and new vessels are formed (Carmeliet and Jain, 2000). Vascular endothelial cells can also secrete vascular growth factors to promote the proliferation of vascular endothelial cells and tumor cells. The inhibition of vascular endothelial cells can inhibit the proliferation of tumor cells and increase apoptosis in metastatic tumor cells. Therefore, anti-angiogenic therapy targeting vascular endothelial cells involved in the proliferation and migration can be an effective antitumor strategy.

Platelet-endothelial cell adhesion molecule-1 (PECAM-1), which is also known as CD31, is a key molecule of cell adhesion. In the process of neovascularization, CD31 is closely related to the movement of endothelial cells, and it may be involved in the signal transduction that is responsible for cell adhesion (Sun et al., 2000). CD31-blocking antibodies inhibit angiogenesis that is induced by cytokines and tumors in different animal models (Lertkiatmongkol et al., 2016).

Many studies have suggested that V. segetalis has anticancer and anti-angiogenic effects. We have summarized the pharmacological data and the effects of an herb (Table 3). The results illustrated that V. segetalis extract has anticancer effects in various cancer cells. V. segetalis extract reduced the expression of CD31 in peripheral endothelial cells and reduced the microvessel density in surrounding tissues. Further research revealed that V. segetalis water extract significantly inhibits the proliferation and migration of human mammary epithelial cells (HMECs) in a concentration-dependent manner. This indicates that the main function of V. segetalis extract is to block the proliferation and migration of endothelial cells. V. segetalis has anticancer effects in vitro, and these effects are markedly enhanced in select cancer cells. Other studies demonstrated that V. segetalis extract can decrease the formation of abundant microvessels, which was induced by a basic fibroblast growth factor (bFGF). bFGF is found in almost all mesoderm-derived and neuroectoderm-derived tissues as well as the tumors derived from these tissues. bFGF has been shown to have a mitogenic, chemotactic, and angiogenic activity, which promotes cell growth, differentiation, and motility (Finzel et al., 1984). By analyzing a few literature studies, we determined that V. segetalis extract can reduce the formation and expansion of tumors by suppressing the formation of abundant microvessels and preventing the proliferation and migration of epithelial cells. Additionally, V. segetalis extract will likely to inhibit angiogenesis that is induced by cytokines and tumors by reducing the expression of CD31. Inhibiting angiogenesis was also shown, which often leads to the reduction of tumors; thus, angiogenesis is a critical prerequisite for the tumor formation, and the anti-angiogenic effect of V. segetalis provides a new strategy for treating tumors. Anti-angiogenic drugs that are commonly used in clinical practice include vascular endothelial growth factor (VEGF) monoclonal antibodies (Cao et al., 2015), thalidomide (Bladé et al., 2001), and vandetanib (Vitagliano et al., 2010), but these drugs can cause serious side effects and increase medical costs. The discovery and study of anti-angiogenic effects of V. segetalis have provided new directions for the development of anticancer drugs in the future.

Table 3

Anticancer activity of V. segetalis.

	Model used	Plant part used	Extract type	Admin	Dosage/duration	Control	Results	References
Anti-angiogenesis and anticancer	In vivo. Mice, injection of Lewis lung cancer cells	Seeds, Vaccaria segetalis	Seeds, decocted twice, filtered, decompressed and condensed into concretes, and freeze-dried to powder	Per oral	Mice were fed with the solution (100 μg/mL) prepared with dry powder after the fourth day of inoculation	Baseline control/Negative control	Vaccaria segetalis extract (40 μg) reduced tumors by 58.3%, reduced CD31 expression in peripheral endothelial cells, and reduced the microvessel density in surrounding tissues. It indicated that the extract prevented progress of established tumors and reduced angiogenesis	Feng et al., 2012
	In vitro. MTT assay	Seeds, Vaccaria segetalis	Seeds, decocted twice, filtered, decompressed and condensed into concretes, and freeze-dried to powder	In vitro	Different concentrations (μg/ml)	Negative control	IC50 = 50 μg/mL Vaccaria segetalis extract inhibited the migration of HMECs in a dose-dependent manner. It suggested that the extract can inhibit the migration of vascular endothelial cells	Feng et al., 2012
	In vivo. CAM assay; In vivo. Mice, injection of Matrigels.	Seeds, Vaccaria segetalis	Seeds, decocted twice, filtered, decompressed and condensed into concretes, and freeze-dried to powder	Injection; Matrigels mixed drugs	Prepare the extract as (100 μg / ml) and treat with 10 μL; 100 μL 100 μg/mL Vaccaria segetalis extract	Negative control; Baseline control/Positive control/negative control	The new blood vessel formation in the extract group was significantly reduced The extract significantly reduced the number of invasive endothelial cells in the Matrigel plug and inhibited microvessel formation	Feng et al., 2012
Anti-angiogenesis and Anticancer	In vivo. Mice, subcutaneous injection of H22 cells for solid carcinoma model	Seeds, Vaccaria segetalis	Vaccaria segetalis 70% ethanol extract, purified by D-101 resin column.	Intragastric administrate	Treatment group (1, 2.5, and 5 mg/kg)	Negative control/three treatment groups	The results suggested that mouse body weight increased, CD31 expression in tumor vessels decreased, and the apoptosis in tumor cells and vascular endothelial cells was induced. It implied that the use of Vaccaria segetalis improved the health of mice, and had the effect of inhibiting tumor growth and anti-angiogenesis	Gao Y. Y. et al., 2010
Anticancer	In vitro. Cancer cell line (A549, MCF-7, PC-3, LNCaP) Normal human mammary epithelial cells (HMECs); Antiproliferative assay	Seeds, Vaccaria segetalis	Vaccaria segetalis water extract	In vitro.	Different concentration (μg/ml)	Treatment groups	The result suggested that Vaccaria segetalis had anticancer effects in vitro and these effects are markedly greater in various cancer cells This experiment indicated that Vaccaria segetalis water extract can inhibit proliferation of cancer cell lines	Mark et al., 2005
Anti-angiogenesis	In vivo. Mice, injection of Matrigels.	Seeds, Vaccaria segetalis	Seeds, decocted twice, filtered, decompressed and condensed into concretes, and freeze-dried to powder	Matrigels mixed drugs	0.1 g extract	Negative control/Positive control	Reduction of endothelial cells and decrease of the formation of abundant microvessels induced by basic fibroblast growth factor (bFGF)	Passaniti et al., 1992
Anticancer by promoting apoptosis of cancer cells	In vitro. MTT assay/DNA fragmentation; In vivo. Mice, HepG2 xenograft Kunming	Seeds, Vaccaria segetalis	Segetoside I, standardized by crude ethanol extract, CH2Cl2/MeOH mixture, MeOH–H2O (RP-8 and RP-18 columns) gradient elution	In vitro; Intraperitoneal injection	Different concentration of segetoside I; Segetoside I (1.25, 2.5, 5 mg/kg)	Negative control/Positive control	IC50= 8.62 μM; Dose-dependent DNA fragmentation and increase Bax/Bcl-2 expressions by Segetoside I (0.82, 8.2, 82 μM); Dose-dependent inhibition of tumor growth with segetoside I	Firempong et al., 2016

Tumors are caused by the acceleration of cell proliferation and suppression of apoptosis. Tumor treatment can also be accomplished by inducing apoptosis in tumor cells. Many studies support the apoptotic effect of V. segetalis in cancer cells. The results identified the V. segetalis compounds that have significant antitumor effects, and these are triterpenoid saponins (segetoside H and segetoside I) and some unknown compounds (Gao Y. Y. et al., 2010; Balsevich et al., 2012). Segetosides H and I, which are isolated from V. segetalis, have significant anticancer effects (Table 3; Yun et al., 1998). Previous studies demonstrated that segetoside I can induce DNA fragmentation and the upregulation of apoptosis-related genes, suggesting that the activation of apoptotic signaling events may have been initiated. Segetoside I also suppressed hepatic tumor growth in mice with virtually no cytotoxicity, and prolonged animal survival (Firempong et al., 2016), and thus, it may be an effective candidate for treating tumors. These results suggest that segetosides H and I can induce cancer cell apoptosis by activating apoptotic pathways to prevent the development of cancer, which may make them valuable antitumor chemotherapeutics.

In summary, we propose that V. segetalis extract can exert its anticancer effects in two ways. First, the extract can inhibit the tumor growth and angiogenesis around the tumor and second, it can activate apoptosis pathways in cancer cells. To study the mechanism of the anticancer action of V. segetalis in the future, we should focus on angiogenesis-related and apoptosis-related pathways. Although V. segetalis has been used as traditional Chinese herbal medicine for more than 2000 years, its anticancer effect has been newly proposed in recent years and the current experiments remain in the preclinical stage, including cell and animal models. Deeper mechanism studies and more expansive clinical data are needed to prove and support medication methods, dosages, and other variables. Thus, much work remains before V. segetalis or its extracts can be used to treat patients with cancer.

Inhibition of Apoptosis

Apoptosis is also known as a programmed cell death. Despite its ability to induce apoptosis in tumor cells as mentioned previously, V. segetalis can inhibit apoptosis that is caused by apoptotic factors in normal cells. Vaccarin was shown to exert a potential protective effect in H2O2-injured human EA.hy926 endothelial cells by inhibiting the Notch signaling pathway and downregulating caspase-3, which has a dominant role in the execution of the apoptotic process. Caspase-3 activation is a central link in apoptosis (Xie et al., 2015). H2O2 is often used to develop a validation model, and it stimulates cells to produce reactive oxygen species (ROS) (Schieber and Chandel, 2014). Previous studies revealed that the ROS production and apoptosis can occur simultaneously (Corbacho et al., 2002). Further studies illustrated that vaccarin can suppress a high glucose-induced damage in EA.hy926 cells, which was shown by improved cell viability and migratory ability, and this treatment effectively suppressed the caspase-3 overexpression (Qiu et al., 2016).

The abovementioned studies demonstrated that vaccarin, which is an active ingredient of V. segetalis, can downregulate the apoptotic gene expression that is induced by apoptotic factors, thereby inhibiting apoptosis. We can imagine a clinical role for vaccarin as an antioxidant based on its ability to prevent H2O2-induced apoptosis, specifically as a daily supplement.

Dilation of Blood Vessels

Vasodilators can be used to treat hypertension, coronary atherosclerotic heart disease, angina pectoris, and cerebrovascular sclerosis. V. segetalis is often used to treat headache, hypertension, asthmatic pneumonia, and other diseases. Because of its vasodilatory effects, V. segetalis (Neck) Garcke decoction had a significant concentration-dependent relaxing effect on the norepinephrine-induced precontraction of the rabbit aortic smooth muscle. After removing endothelial cells, the relaxation effect of V. segetalis (Neck) Garcke on noradrenaline-precontracted arterial rings was significantly decreased (Hua'e et al., 2007). Morita et al. (1997a) found that segetalins A, D, F, G, and H exhibited vasodilatory activity against norepinephrine-induced aortic contraction in rats, and among these, segetalins G and H had the strongest diastolic activity. In addition, a study by Jing et al. (2007) reported the same relaxation in aortic ring samples that lacked an endothelium. The volatile oil in V. segetalis may be responsible for this function (Shiva Kumar et al., 2017). The specific mechanisms of segetalin action on vasodilation and contractile activity require further investigation. Previously, we explained that TCM often uses the seeds of V. segetalis to mechanically stimulate auricular points to assist in the treatment of hypertension. In addition to the unique characteristics of its seeds, we speculate that it is also possible that the volatile oil of V. segetalis could enter the body through the skin at the ear point. (Morita et al., 2006) found that the segetalins in V. segetalis extract have a vasodilatory activity. Although the vasodilatory activity of segetalins has been reported in animal models, there are no clinical data to date. However, the evidence points to a new strategy for the treatment of vasoconstriction-related diseases.

Promotion of Lactation

A recent study indicated that the use of V. segetalis during breastfeeding to promote breast milk is common in Macau (Zheng et al., 2020). Many studies have revealed that V. segetalis, Leonurus, and Astragalus can significantly promote lactation in female rats (Baoming and Anshan, 2007). Although this treatment remains in use, the mechanism by which V. segetalis induces lactation is unclear.

One of the primary ingredients in V. segetalis is vaccarin (Jia et al., 1998), which promotes the proliferation of mammary epithelial cells and enhances their secretory function (Leonoudakis et al., 2010). Mammary epithelial cells are the breast biological generators that synthesize and secrete milk. The number and activity of mammary epithelial cells are closely related to the lactation performance of livestock (Planas-Silva et al., 2006). The latest research has enriched the lactation mechanism of Vaccarin. Vaccarin and PRL have similar effects in stimulating the proliferation of breast epithelial cells and enhancing their secretory function, the expression of Cylin D1, the phosphorylation of mechanistic target of rapamycin (mTOR), and the regulation of the expression of a sterol regulatory element binding protein 1c (SREBP-1c). In addition, Vaccarin can promote the expression of PRL receptors. In summary, Vaccarin can promote the breast epithelial cell proliferation and enhance its secretion ability via the PRL receptor-PI3K-Cyclin D1/SREBP-1c/mTOR signaling pathways (Yu et al., 2020). JAK2 is important for the PRL signal transduction and normal breast tissue development, and STAT5a is necessary for the breast development (Gass et al., 2003). β-casein is an important milk protein, and its secretion level reflects the lactation ability of breast epithelial cells to a certain extent. Gao X. J. et al. (2010) found that the dibutyl phthalate (DBP) injection can increase the milk production in cows. Liu et al. (2010) found that DBP could significantly increase the proliferation and viability of mammary epithelial cells in dairy cows. It was also found that DBP could increase the β-casein expression and lactose secretion in breast epithelial cells (Tong et al., 2013). In addition, Tong et al. found that DBP from V. segetalis can promote lactation and the proliferation of breast epithelial cells and activate a JAK-STAT5-signaling pathway by increasing the STAT5 phosphorylation levels (Tong et al., 2011). These studies demonstrated that DBP has estrogenic activity, and that it can activate a lactation-signaling pathway and promote lactation by regulating the milk protein, lactose, and milk fat synthesis. However, as a highly toxic substance, the dosage and application of DBP require more theoretical research and experimental support.

The low postpartum lactation ability of mammals is mainly attributable to the insufficient activation of the relevant endocrine system in the body, preventing mammary glands from producing milk normally and hindering milk excretion. Chinese herbal medicine can promote lactation by regulating the metabolism of postpartum mammals and increasing endocrine levels in vivo. Kleinberg and Ruan (2008) found that V. segetalis increased the content of growth hormones (GHs) and PRL in serum from dairy cows, which in turn promoted the breast development and improved the lactation performance. Jun-Xian et al. (2013) used V. segetalis water extract, which had a similar effect to estrogen and PRL, and its components could bind to an estrogen receptor to activate a STAT5-signaling pathway, thereby promoting the P-STAT5 expression and milk protein synthesis. Bryant (2009) found that the PRL promoter transcription and PRL synthesis can be induced by stimulating the estrogen receptor system and pituitary transcription factor Pit-1. PRL controls the regulation of milk protein at the translational level, thereby promoting the synthesis of milk proteins. Another study reported similar results and suggested that V. segetalis has a specific estrogen-like effect; specifically, its components can bind to an estrogen receptor, and thereby promoting the synthesis of PRL (Itokawa et al., 1995).

Based on these findings, we concluded that the stimulatory effects of V. segetalis on the production of milk occur through DBP and that DBP has PRL-like effects. In addition, a few studies have found that the other substances in V. segetalis have estrogen-like effects, and estrogen-like active ingredients can bind with estrogen receptors to promote the synthesis of PRL. This implies a synergy between the actions of various substances in V. segetalis. These results provide new ideas for future studies on V. segetalis.

Estrogen-Like Action

Many studies have revealed the estrogen-like effect of V. segetalis. Pakoussi et al. (2018) found that phytoestrogens enhance uterine contractions. Morita et al. (1997c) discovered vaccaroid A in V. segetalis and found that it has a role in promoting uterine contractions. Moreover, the research has illustrated that segetalins A, B, G, and H are cyclic hexapeptides and pentapeptides with estrogenic activity in ovariectomized rats (Morita et al., 1993, 1995; Yun et al., 1997). Segetalins are the only natural cyclic peptides that were reported to have estrogenic activity. When they are digested into acyclic segetalins by enzymes, they lose their activity, indicating that their conformation plays an important role in their function (Morita et al., 1997a). A study found that segetalins G and H at a dose of 2.5 mg/kg significantly increased uterine weight vs. the control (p < 0.01) in ovariectomized rats that did not receive the estrogen supplementation for 2 weeks (Yun et al., 1997). Itokawa et al. (1995) applied segetalins A and B to ovariectomized rats for 14 consecutive days and observed similar effects to those of segetalins G and H, verifying that segetalins A, B, G, and H have estrogen-like effects. Ovariectomy-induced bone loss in rats and postmenopausal bone loss in women share many similar features, and the clinical symptoms are often treated by 17β-estradiol supplementation (Kalu, 1991). To study the estrogen-like activity of V. segetalis and facilitate its future clinical applications, Shih et al. (2009) constructed an ovariectomized rat model to simulate postmenopausal bone loss in women. In the ovariectomized group, the calcium content of the femur and the fourth lumbar vertebra was significantly reduced, whereas these effects were alleviated by the supplementation with 17β-estradiol or V. segetalis extract. V. segetalis extract does not cause side effects such as uterine or vaginal hypertrophy. This provides a new direction for the treatment of osteoporosis. Moreover, because of its estrogen-like activity, V. segetalis can be used as an alternative to estrogen for people with allergies to synthetic estrogens. In addition, V. segetalis can avoid the side effects of estrogen supplementation.

Toxicology Research

Several toxicological studies related to V. segetalis have been conducted. In one study, V. segetalis extract obtained via a reflux with 75% ethanol was used to treat mice. The minimum toxic amount of V. segetalis extract in mice was 100 mg/kg, and the minimum lethal dose was 1,500 mg/kg. V. segetalis extract was more toxic to the heart and kidneys of mice at 1,000 mg/kg (approximately lethal dose) than lung, and there was no serious functional damage in mice treated with 200 mg/kg of V. segetalis extract. Therefore, V. segetalis shows a good safety profile, and it could be a promising therapeutic modality (Gao et al., 2013).

Segetoside I is an extract of V. segetalis, and it has been a focus of research. One study showed that intraperitoneal segetoside I in mice had an LD50 (median lethal dose) of 14.5 mg/kg (Firempong et al., 2016). The mice were treated with segetoside I at different concentrations and sacrificed after 14 days, and their respective organ coefficients were determined. The tissue coefficients of the heart, liver, and kidney did not change significantly, whereas the tissue coefficient of the spleen increased with increasing doses of segetoside I. The spleen coefficient was significantly improved by segetoside I at the concentration of 1.25, 2.5, and 5 mg/kg. This demonstrated that segetoside I did not significantly affect the body weight of mice, but that it damaged the spleen at doses exceeding 5 mg/kg. In addition, the studies have explored the cytotoxic effects of different extracts of V. segetalis in different cells, and IC50 was obtained (Table 4; Ma et al., 2008).

Table 4

Cytotoxic activity (IC50, mM) of compounds 1–6.

Cell lines	1	2	3	4	5	6	Topotecan	Docetaxel
LNcap	3.6	3.4	2.5	4.2	12.9	1.2	0.053
A-549	1.0	3.0	11.0	1.0	7.2	0.4		<0.01
P-388	0.8	9.4	0.7	3.7	1.6	0.1		<0.01

Compound 1, vaccaroside I; Compound 2, vaccaroside E; Compound 3, vaccaroside G; Compound 4, vaccaroside B; Compound 5, segetoside H; Compound 6, segetoside I.

LNCaP, human prostate cancer cell line; A549, human lung cancer cell line; P388, mouse leukemia cell line.

Topotecan and docetaxel were used as positive controls.

In a previous study, it was mentioned that V. segetalis has an anti-inflammatory effect, but at the same time it has an estrogen-like effect, which also leads to certain side effects. Overdose of estrogen by men who have not entered puberty will cause the secondary sex characteristics of men to not appear but the second sex characteristics of women; excessive estrogen in puberty men will cause a gradual decline of the second sex characteristics of men, in addition to causing endocrine disorders, obesity, and even affect fertility (Kabir et al., 2015). This has led to a clinical application of Wang Buliuxing more oriented to females, and whether Wang Buliuxing can be used for the treatment of males and the applied dosage need more literature support. In addition, the anti-inflammatory effect of Wang Buliu Xing may hide an inflammatory process caused by the microorganism infection, which may lead to an aggravation of the infection, and thus may not fundamentally solve the problem.

Taken together, the toxicological information on V. segetalis remains extremely limited, and further research is required to determine the extraction, purification, and application of the active ingredients of V. segetalis.

Conclusion

V. segetalis is a plant used in traditional Chinese herbal medicine that occupies an extremely important position in the Chinese medicine theory. With an increasing amount of research on the active ingredients of V. segetalis, V. segetalis could be used with modern medicine to treat blood strangury, lactation deficiencies, and chylorrhea. V. segetalis can also be used to treat hypertension, headache, and gallstones through its unique ability to physically stimulate the corresponding acupuncture points on the ear or body. This article has provided in detail the chemical and pharmacological properties of V. segetalis and summarized the recent literature studies. The main ingredients in V. segetalis include flavonoids, cyclic peptides, saponins, and polysaccharides, but several active substances have not been identified, indicating the need for a more systematic phytochemical research. In terms of its pharmacological effects, V. segetalis has anti-inflammatory, anti-angiogenic, anticancer, anti-apoptosis, and estrogenic effects, dilates blood vessels, and promotes lactation. Many diseases are treated poorly using modern medicine, and traditional and complementary medicine can provide new treatment modalities for these diseases.

Although substantial research has been conducted on V. segetalis, many unknown elements in V. segetalis remain. In addition, some studies used hydroalcoholic crude extracts instead of the pure active ingredients of V. segetalis as the experimental objects. We speculate that hydroalcoholic crude extracts are used because the extraction process for the active ingredients of V. segetalis is more complicated. In addition, we found that V. segetalis crude extracts and some effective active ingredients also have anticancer effects that have not been mentioned in clinical applications, thereby further enhancing the significance of V. segetalis in modern research and providing new directions of future research.

Future research on V. segetalis should specifically focus on the four issues that are described below. First, we should continue to explore the unknown elements in V. segetalis. Second, the processes for extracting the effective active substances of V. segetalis should be further improved. Third, the mechanisms of the anti-inflammatory, anticancer, and anti-apoptotic effects of V. segetalis should be further elucidated. Finally, more research on the pharmacology and toxicology is needed to provide additional evidence for clinical applications.

Author Contributions

CL, XZ, and MT conceptualized the study. MT, YH, XW, TC, CY, NW, ZZ, and BZ investigated the study. MT wrote original draft preparation. CL and XZ helped in writing and editing the review. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.